Literature DB >> 15711783

Safety of endotoxin challenge in healthy volunteers: bradycardia.

Bernd Jilma.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15711783     DOI： 10.1007/s00134-005-2562-z

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  6 in total

1.  Asystole following endotoxin administration.

Authors:  W V Williams; T Fullerton; J C Fox; M B Enslin; L Murray; D Jorkasky
Journal:  J Endotoxin Res       Date:  2000

Review 2.  Human models of innate immunity: local and systemic inflammatory responses.

Authors:  C Fiuza; A F Suffredini
Journal:  J Endotoxin Res       Date:  2001

3.  Acetaminophen has greater antipyretic efficacy than aspirin in endotoxemia: a randomized, double-blind, placebo-controlled trial.

Authors:  T Pernerstorfer; R Schmid; C Bieglmayer; H G Eichler; S Kapiotis; B Jilma
Journal:  Clin Pharmacol Ther       Date:  1999-07       Impact factor: 6.875

4.  Pharmacodynamics of active site-inhibited factor VIIa in endotoxin-induced coagulation in humans.

Authors:  Bernd Jilma; Claudia Marsik; Florian Mayr; Monika T Graninger; Fletcher B Taylor; Mette C Ribel; Elisabeth Erhardtsen; Sylvia Handler; Hans Georg Eichler
Journal:  Clin Pharmacol Ther       Date:  2002-10       Impact factor: 6.875

5.  Severe vagal response after endotoxin administration in humans.

Authors:  Lucas T G J van Eijk; Peter Pickkers; Paul Smits; Martijn P W J M Bouw; Johannes G van der Hoeven
Journal:  Intensive Care Med       Date:  2004-10-26       Impact factor: 17.440

Review 6.  Response of man to endotoxin.

Authors:  G D Martich; A J Boujoukos; A F Suffredini
Journal:  Immunobiology       Date:  1993-04       Impact factor: 3.144
  6 in total
  1 in total

1.  Immunomodulatory effects of fosfomycin in experimental human endotoxemia.

Authors:  Robert Sauermann; Claudia Marsik; Ilka Steiner; Katja Seir; Tuende Cvitko; Markus Zeitlinger; Oswald Wagner; Christian Joukhadar
Journal:  Antimicrob Agents Chemother       Date:  2007-03-12       Impact factor: 5.191
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.